Cost-Effectiveness of Cervical Cancer Screening With Human Papillomavirus DNA Testing and HPV-16,18 Vaccination

Human papillomavirus and cervical cancer

2007 • 2,789 citations

Quadrivalent Vaccine against Human Papillomavirus to Prevent High-Grade Cervical Lesions

2007 • 2,003 citations

Quadrivalent Vaccine against Human Papillomavirus to Prevent Anogenital Diseases

2007 • 1,820 citations

Sustained efficacy up to 4·5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial

2006 • 1,766 citations

Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial

2007 • 1,287 citations

2001 Consensus Guidelines for the Management of Women With Cervical Cytological Abnormalities

2002 • 1,232 citations

Overview of the European and North American studies on HPV testing in primary cervical cancer screening

2006 • 1,084 citations

The natural history of cervical HPV infection: unresolved issues

2006 • 1,000 citations

American Cancer Society Guideline for the Early Detection of Cervical Neoplasia and Cancer

2002 • 930 citations

Effect of prophylactic human papillomavirus L1 virus-like-particle vaccine on risk of cervical intraepithelial neoplasia grade 2, grade 3, and adenocarcinoma in situ: a combined analysis of four randomised clinical trials

2007 • 581 citations

Projected Clinical Benefits and Cost-effectiveness of a Human Papillomavirus 16/18 Vaccine

2004 • 541 citations

Chapter 9: Clinical applications of HPV testing: A summary of meta-analyses

2006 • 538 citations

Interim Guidance for the Use of Human Papillomavirus DNA Testing as an Adjunct to Cervical Cytology for Screening

2004 • 506 citations

Model for Assessing Human Papillomavirus Vaccination Strategies

2007 • 484 citations

Cervical adenocarcinoma and squamous cell carcinoma incidence trends among white women and black women in the United States for 1976–2000

2004 • 437 citations

Cervical Cancer in Women With Comprehensive Health Care Access: Attributable Factors in the Screening Process

2005 • 375 citations

Report of Nationally Representative Values for the Noninstitutionalized US Adult Population for 7 Health-Related Quality-of-Life Scores

2006 • 372 citations

Potential Health and Economic Impact of Adding a Human Papillomavirus Vaccine to Screening Programs

2003 • 347 citations

Cost Effectiveness of a Potential Vaccine forHuman papillomavirus

2003 • 321 citations

Epidemiology of HPV 16 and Cervical Cancer in Finland and the Potential Impact of Vaccination: Mathematical Modelling Analyses

2006 • 286 citations

Cost-effectiveness of Alternative Triage Strategies for Atypical Squamous Cells of Undetermined Significance

2002 • 272 citations

Cost-Effectiveness of Human Papillomavirus DNA Testing for Cervical Cancer Screening in Women Aged 30 Years or More

2004 • 209 citations

2001 Consensus Guidelines for the Management of Women with Cervical Cytological Abnormalities

2002 • 200 citations

Assessing the Annual Economic Burden of Preventing and Treating Anogenital Human Papillomavirus-Related Disease in the US

2005 • 194 citations

Are Pharmaceuticals Cost-Effective? A Review Of The Evidence

2000 • 182 citations

The potential cost-effectiveness of prophylactic human papillomavirus vaccines in Canada

2007 • 181 citations

Papanicolaou smear history and diagnosis of invasive cervical carcinoma among members of a large prepaid health plan

2000 • 180 citations

The frequency of Pap smear screening in the United States

2004 • 173 citations

Cost-effectiveness of HPV 16, 18 vaccination in Brazil

2007 • 170 citations

Cervical cancer screening among U.S. women: analyses of the 2000 National Health Interview Survey

2004 • 167 citations

Chapter 21: Modelling the impact of HPV vaccines on cervical cancer and screening programmes

2006 • 163 citations

The value of including boys in an HPV vaccination programme: a cost-effectiveness analysis in a low-resource setting

2007 • 160 citations

Impact of the National Breast and Cervical Cancer Early Detection Program on mammography and pap test utilization among white, Hispanic, and African American women: 1996–2000

2006 • 152 citations

Chapter 13: Primary Screening of Cervical Cancer With Human Papillomavirus Tests

2003 • 144 citations

Chapter 10: New dimensions in cervical cancer screening

2006 • 140 citations

The health care costs of cervical human papillomavirus–related disease

2004 • 138 citations

Nonattendance is still the main limitation for the effectiveness of screening for cervical cancer in the Netherlands

2006 • 122 citations

Cost-effectiveness of Human Papillomavirus DNA Testing in the United Kingdom, The Netherlands, France, and Italy

2005 • 121 citations

Estimating CE Ratios under Second-order Uncertainty

1997 • 118 citations

From cost-effectiveness ratios to resource allocation : Where to draw the line?

1995 • 112 citations

Estimating the long-term impact of a prophylactic human papillomavirus 16/18 vaccine on the burden of cervical cancer in the UK

2006 • 112 citations

Cost-Effectiveness Analysis Based on the Atypical Squamous Cells of Undetermined Significance/Low-Grade Squamous Intraepithelial Lesion Triage Study (ALTS)

2006 • 99 citations

ACOG Practice Bulletin Number 45, August 2003: Committee on Practice Bulletins-Gynecology. Cervical Cytology Screening

2003 • 95 citations

Modeling human papillomavirus and cervical cancer in the United States for analyses of screening and vaccination

2007 • 90 citations

Chapter 18: Public health policy for cervical cancer prevention: The role of decision science, economic evaluation, and mathematical modeling

2006 • 90 citations

Chapter 19: Cost-effectiveness of cervical cancer screening

2006 • 82 citations

Race-specific results of Papanicolaou testing and the rate of cervical neoplasia in the National Breast and Cervical Cancer Early Detection Program, 1991-1998 (United States).

2001 • 73 citations

The cost-effectiveness of influenza vaccination of healthy adults 50–64 years of age

2005 • 69 citations

An evaluation of liquid-based cytology and human papillomavirus testing within the UK cervical cancer screening programme

2004 • 65 citations

TIME COSTS ASSOCIATED WITH CERVICAL CANCER SCREENING

2001 • 56 citations

Chapter 14: Role of Triage Testing in Cervical Cancer Screening

2003 • 56 citations

Benefits and costs of immunization of children with pneumococcal conjugate vaccine in Canada

2003 • 56 citations

Cost-Effectiveness Analysis of Liquid-Based Cytology and Human Papillomavirus Testing in Cervical Cancer Screening

2006 • 56 citations

Economic evaluation of an extended acellular pertussis vaccine programme for adolescents in Ontario, Canada

2004 • 44 citations

Cost-effectiveness of Extending Cervical Cancer Screening Intervals Among Women With Prior Normal Pap Tests

2006 • 41 citations

Screening history of women with cervical cancer: a 6-year study in Aarhus, Denmark

2008 • 33 citations

CHAPTER 10 A public health approach to cervical cancer control: Considerations of screening and vaccination strategies

2006 • 33 citations

Costs of running a universal adolescent hepatitis B vaccination programme

2005 • 29 citations

An economic analysis of a pneumococcal vaccine programme in people aged over 64 years in a developed country setting

2005 • 29 citations

Chapter 11: Future Directions in Cervical Pathology

2003 • 26 citations

Collecting Direct Non-Health Care and Time Cost Data: Application to Screening and Diagnosis of Cervical Cancer

2006 • 24 citations

Cost-effectiveness of cervical cancer screening.

1983 • 15 citations

A study of Pap test history and histologically determined cervical cancer in NSW women, 1997–2003

2005 • 9 citations

Deleted Work

1955 • 0 citations